MedTrace Logo

Warrior CARE: Cannabis Behavioral Health

NCT06381180 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-09-29

No results posted yet for this study

Summary

This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.

Conditions

  • Post Traumatic Stress Disorder
  • Cannabis Use
  • Suicide
  • Veterans
  • Marijuana

Interventions

DRUG

Tetrahydrocannabinol

Plant cannabis that will be smoked

DRUG

Cannabidiol

Plant cannabidiol that will be smoked

DRUG

Placebo

Plant will be smoked.

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-22
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381180 on ClinicalTrials.gov